Cargando…
The subtle nuances of intranasal corticosteroids
BACKGROUND: In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with i...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968222/ https://www.ncbi.nlm.nih.gov/pubmed/33731223 http://dx.doi.org/10.1186/s40463-020-00480-z |
_version_ | 1783666019906093056 |
---|---|
author | Fowler, James Rotenberg, Brian W. Sowerby, Leigh J. |
author_facet | Fowler, James Rotenberg, Brian W. Sowerby, Leigh J. |
author_sort | Fowler, James |
collection | PubMed |
description | BACKGROUND: In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with industry. The purpose of this commentary is to review the nuances of each intranasal corticosteroid. COMMENTARY: There are nine intranasal corticosteroids approved for use in Canada. Each are discussed in detail, including their indication, bioavailability, effects on intranasal environment, and factors around patient adherence. Off-label use of budesonide irrigations is also discussed and cost information is presented in reference format for all available intranasal corticosteroids. CONCLUSION: Although the efficacy of each intranasal corticosteroid has been shown to be similar, prescribing should be tailored based on bioavailability, intranasal environment, and factors that impact patient adherence such as dosing, cost and tolerability. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-7968222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79682222021-03-22 The subtle nuances of intranasal corticosteroids Fowler, James Rotenberg, Brian W. Sowerby, Leigh J. J Otolaryngol Head Neck Surg Commentary BACKGROUND: In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with industry. The purpose of this commentary is to review the nuances of each intranasal corticosteroid. COMMENTARY: There are nine intranasal corticosteroids approved for use in Canada. Each are discussed in detail, including their indication, bioavailability, effects on intranasal environment, and factors around patient adherence. Off-label use of budesonide irrigations is also discussed and cost information is presented in reference format for all available intranasal corticosteroids. CONCLUSION: Although the efficacy of each intranasal corticosteroid has been shown to be similar, prescribing should be tailored based on bioavailability, intranasal environment, and factors that impact patient adherence such as dosing, cost and tolerability. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-03-17 /pmc/articles/PMC7968222/ /pubmed/33731223 http://dx.doi.org/10.1186/s40463-020-00480-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Fowler, James Rotenberg, Brian W. Sowerby, Leigh J. The subtle nuances of intranasal corticosteroids |
title | The subtle nuances of intranasal corticosteroids |
title_full | The subtle nuances of intranasal corticosteroids |
title_fullStr | The subtle nuances of intranasal corticosteroids |
title_full_unstemmed | The subtle nuances of intranasal corticosteroids |
title_short | The subtle nuances of intranasal corticosteroids |
title_sort | subtle nuances of intranasal corticosteroids |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968222/ https://www.ncbi.nlm.nih.gov/pubmed/33731223 http://dx.doi.org/10.1186/s40463-020-00480-z |
work_keys_str_mv | AT fowlerjames thesubtlenuancesofintranasalcorticosteroids AT rotenbergbrianw thesubtlenuancesofintranasalcorticosteroids AT sowerbyleighj thesubtlenuancesofintranasalcorticosteroids AT fowlerjames subtlenuancesofintranasalcorticosteroids AT rotenbergbrianw subtlenuancesofintranasalcorticosteroids AT sowerbyleighj subtlenuancesofintranasalcorticosteroids |